Psychedelics in Psychiatry: Promise vs. Proof
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Psychedelics in Psychiatry: Promise vs. Proof
-
Narrated by:
-
By:
Send us questions here!
Are psychedelics the future of psychiatry—or just another wave of hype? In this episode, Maria and Tabitha sit down with John Greeley to break down what the research really says about psychedelics like psilocybin, MDMA, and ketamine. We cover safety, harm reduction, cultural concerns, and what clinicians and patients alike need to know.
✨ Learn about:
- The science behind psychedelics and the brain
- Why harm reduction matters
- How providers can support patients using psychedelics
- The cultural and ethical tensions shaping this field
🔔 Subscribe for more honest, neurodivergent-affirming conversations on mental health.
📖 Learn more: paperflowerpsychiatry.com
Socials:
Facebook: Paperflower Psychiatry
Instagram&Threads: @paperflowerpsychiatry
Tiktok: @dr.mariaingalla
Websites:
www.paperflowerpsychiatry.com
www.paperflowerinstitute.com
www.courses.paperflowerinstitute.com
adbl_web_anon_alc_button_suppression_t1
No reviews yet